The DEA Has Descheduled Prescription CBD for Severe Epilepsy
Click here for a message from The Motley Fool Co-Founders Tom and David Gardner. Marketing Epidiolex is about to get a lot easier for GW Pharmaceuticals. Parents of children with early-onset epilepsy and their physicians will find it easier to fill their next Epidiolex prescriptions. That’s because the CBD tincture from GW Pharmaceuticals (NASDAQ:GWPH) is…